Dose Effect Evaluation and Therapeutic Window of the Neuro-EPO Nasal Application for the Treatment of the Focal Ischemia Model in the Mongolian Gerbil

Cerebrovascular disease is the third leading cause of death and the leading cause of disability in Cuba and in several developed countries. A possible neuroprotective agent is the rHu-EPO, whose effects have been demonstrated in models of brain ischemia. The Neuro-EPO is a derivative of the rHu-EPO...

Descripción completa

Detalles Bibliográficos
Autores principales: Teste, Iliana Sosa, Tamos, Yuneidys Mengana, Cruz, Yamila Rodríguez, Cernada, Adriana Muñoz, Rodríguez, Janette Cruz, Martínez, Nelvis Subirós, Antich, Rosa Maria Coro, González-Quevedo, Alina, Rodríguez, Julio Cesar García
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Scientific World Journal 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3366217/
https://www.ncbi.nlm.nih.gov/pubmed/22701364
http://dx.doi.org/10.1100/2012/607498

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3366217/
https://www.ncbi.nlm.nih.gov/pubmed/22701364
http://dx.doi.org/10.1100/2012/607498

Ejemplares similares